Dr. Chad E. Brekelbaum, MD

Dr. Brekelbaum practices at Northwest Arkansas Urology Associates in Springdale, Arkansas.

Dr. Brekelbaum's NPI, 1730145954, was assigned on April 25, 2006. Dr. Brekelbaum graduated from University of Texas Medical Branch at Galveston in 1998. Dr. Brekelbaum holds Arkansas license E-3636.

Dr. Brekelbaum's primary practice is Northwest Arkansas Urology Associates, at 5401 Willow Creek Dr, Springdale, AR 72762 in Washington County. The practice phone is (479) 521-8980.

Dr. Brekelbaum's primary practice is Northwest Arkansas Urology Associates in Springdale, Arkansas. Dr. Brekelbaum is also affiliated with Freeman Health System - Springdale Medical Center. The medical group on file is Northwest Arkansas Urology Associates. Dmand AI also links Dr. Brekelbaum to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brekelbaum practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Brekelbaum's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Brekelbaum is licensed in Arkansas.

CMS data shows 2,050 Medicare services from Dr. Brekelbaum across 16 procedure codes in 2024, for 469 Medicare patients. Medicare paid $65,835 for them.

CMS counts 469 Medicare patients who saw Dr. Brekelbaum in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brekelbaum's median patient age at 67, with 22% women.

In 2024, Dr. Brekelbaum wrote 2,472 Medicare Part D claims for 476 patients. 86% of them were for generic drugs. CMS names the drug for 2,334 of them, across 34 drugs with 11 or more claims each, at $244,288 in total drug cost. In 2023, CMS named 2,118 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Brekelbaum for performance year 2024, reported individually. Dr. Brekelbaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of prostate resection by Dr. Brekelbaum, more than 63% of the clinicians it reports for that procedure.

CMS Open Payments shows 385 general payments to Dr. Brekelbaum from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Axonics, Inc. paid the most, $4,645.

Dr. Brekelbaum graduated from University of Texas Medical Branch at Galveston in 1998.